Clinical Trials for Recurrent Glioblastoma

Find clinical trials for recurrent glioblastoma. Discover research opportunities and treatment options in your area.

49 Active Trials Found

Showing 49 trials on this page

Page 2 of 3

DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma

NCT ID: NCT03115333

This clinical trial is studying a special type of brain imaging called dynamic susceptibility contrast-enhanced magnetic resonance imaging (DSC-MRI) to see how well it can measure blood flow change...

Recruiting

Phase: NA Type: interventional Locations: Rochester, Minnesota, United States, Durham, North Carolina, United States +56 more

A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma

NCT ID: NCT06552260

This clinical trial is investigating a new treatment called troriluzole for patients with recurrent glioblastoma, a type of aggressive brain tumor. The study aims to see if this drug can help peopl...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Boston, Massachusetts, United States +2 more

OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial

NCT ID: NCT06558214

The OPTIMUS PRIME clinical trial is studying a new treatment approach for adults with recurrent glioblastoma, a type of aggressive brain cancer. This study is looking at the safety and feasibility ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Gainesville, Florida, United States

RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)

NCT ID: NCT06389591

This clinical trial is studying a new type of vaccine called RNA-Lipid Particle (RNA-LP) vaccines for adults with recurrent glioblastoma, a type of brain cancer that comes back after treatment. The...

Recruiting

Phase: PHASE1 Type: interventional Locations: Gainesville, Florida, United States

Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma

NCT ID: NCT05039281

This clinical trial is testing a combination of two medications, atezolizumab and cabozantinib, to see if they can help treat patients with recurrent glioblastoma, a type of brain cancer that has c...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma

NCT ID: NCT04590664

This clinical trial is examining a medication called Visudyne (liposomal verteporfin) to see how well it works and what side effects it may have for patients with recurrent high-grade glioblastoma,...

Recruiting

Phase: PHASE1 Type: interventional Locations: Atlanta, Georgia, United States

Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells

NCT ID: NCT06186401

This clinical trial is studying a new treatment called E-SYNC CAR T-cell therapy for patients with a specific type of brain cancer known as glioblastoma that has a certain genetic mutation (EGFRvII...

Recruiting

Phase: PHASE1 Type: interventional Locations: San Francisco, California, United States

Surgical Pembro +/- Olaparib w TMZ for rGBM

NCT ID: NCT05463848

This clinical trial is exploring a new combination therapy for patients with recurrent glioblastoma (GBM), which is a type of brain tumor that comes back after initial treatment. The study is testi...

Recruiting

Phase: PHASE2 Type: interventional Locations: Boston, Massachusetts, United States, Boston, Massachusetts, United States +3 more

A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial

NCT ID: NCT06069726

The MOAB Trial is a clinical study exploring whether a treatment called atezolizumab can help patients with recurrent glioblastoma, a type of brain cancer, especially those with a low mutational bu...

Recruiting

Phase: PHASE2 Type: interventional Locations: Salt Lake City, Utah, United States, Durham, North Carolina, United States +1 more

A Clinical Trial on Combined (Neo-)Adjuvant Intravenous Plus Intracranial Administration of Ipilimumab and Nivolumab in Recurrent Glioblastoma

NCT ID: NCT06097975

This clinical trial is investigating a new treatment approach for patients with recurrent glioblastoma, a type of brain cancer that has come back after previous treatment. The goal of the study is ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Brussels, , Belgium

Sonodynamic Therapy in Patients With Recurrent GBM

NCT ID: NCT06039709

This clinical trial is exploring a new treatment approach for patients with recurrent glioblastoma (GBM), a type of brain cancer that often has limited options for care. The study is testing a comb...

Recruiting

Phase: PHASE1 Type: interventional Locations: Charlottesville, Virginia, United States

Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma

NCT ID: NCT06160206

This clinical trial is studying a new treatment approach for patients with recurrent glioblastoma, a type of brain cancer that has come back after treatment. The trial is testing a combination of t...

Recruiting

Phase: PHASE2 Type: interventional Locations: Rochester, Minnesota, United States, Scottsdale, Arizona, United States +1 more

Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields

NCT ID: NCT04469075

This clinical trial is studying how two topical lotions—clindamycin and triamcinolone—can help prevent skin-related side effects caused by a treatment called Tumor Treating Fields (TTFields) in peo...

Recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States, New York, New York, United States +7 more

Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma

NCT ID: NCT04201873

This clinical trial is exploring a new treatment approach for patients with recurrent glioblastoma, a type of brain cancer that has come back after initial treatment and can be surgically removed. ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Los Angeles, California, United States, Los Angeles, California, United States

Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma

NCT ID: NCT06090903

This clinical trial is studying how magnetic resonance imaging (MRI) can help us understand the biology of brain tumors, specifically in patients with glioblastoma that can be surgically removed. G...

Recruiting

Phase: NA Type: interventional Locations: Los Angeles, California, United States

Role of Repeat Resection in Recurrent Glioblastoma

NCT ID: NCT04838782

This clinical trial is studying the potential benefits of performing repeat surgery on patients with recurrent glioblastoma, a type of aggressive brain tumor. While past research suggests that goin...

Recruiting

Phase: NA Type: interventional Locations: Edmonton, Alberta, Canada

Identification of Treatment Concentrations of Defactinib or VS-6766 for the Treatment of Patients With Glioblastoma

NCT ID: NCT05798507

This clinical trial is testing two new drugs, defactinib and VS-6766, to see how well they work together in treating glioblastoma, a type of aggressive brain cancer. Researchers believe that these ...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Atlanta, Georgia, United States

Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma

NCT ID: NCT05284643

This clinical trial is studying a new way to find and treat recurrent glioblastoma, a type of aggressive brain cancer. Researchers want to see if a special MRI scan called spectroscopic MRI can hel...

Recruiting

Phase: NA Type: interventional Locations: Miami, Florida, United States

Natural Progesterone for the Treatment of Recurrent Glioblastoma

NCT ID: NCT05091866

This clinical trial is looking at the use of natural progesterone, a hormone that the body produces, to see if it can help treat patients whose glioblastoma, a type of brain cancer, has come back a...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Atlanta, Georgia, United States

Tris-CAR-T Cell Therapy for Recurrent Glioblastoma

NCT ID: NCT05577091

This clinical trial is studying a new treatment called Tris-CAR-T cell therapy for patients with recurrent glioblastoma, a type of brain cancer that comes back after treatment. The trial is in its ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Beijing, Beijing, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions